查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1485771

护理点基因检测市场，按样本、按产品、按平台、按最终用户、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Point of Care Genetic Testing Market, By Sample, By Product, By Platform, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年，即时基因检测市场规模为 65.8354 亿美元，2024 年至 2032 年复合年增长率为 12.35%。

即时基因检测市场-市场动态

全球传染病发生率上升

全球性传染病的日益普及正在推动对即时基因检测 (POCGT) 的需求不断增加。根据国家医学图书馆的数据，传染病仍然是导致全球发病和死亡的主要因素之一，每年在全球范围内导致超过 5,200 万人 (33%) 死亡。由于传染病在全球范围内构成了重大的公共卫生挑战，因此迫切需要可直接在护理点部署的快速、准确的诊断解决方案。传统的实验室为基础的检测方法通常会延迟诊断和治疗开始，这可能会加剧传染病的传播。 POCGT 透过提供及时结果来应对这项挑战，使医疗保健提供者能够及时识别传染源并启动适当的治疗策略。

护理点基因检测市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 12.35% 左右的复合年增长率成长

根据样本细分，预计血液将在 2023 年显示最大的市场份额

从平台细分来看，横向层析侦测是2023年的主导类型

根据最终用户细分，临床实验室是 2023 年的主导类型

按地区划分，北美是 2023 年的主要收入来源

护理点基因检测市场-細項分析：

全球护理点基因检测市场根据样本、产品、平台、最终用户和地区进行细分。

根据样本，市场分为两类：血液包括使用血液样本进行的基因检测和诊断程序，提供对各种健康状况的深入了解，例如传染病、遗传性疾病和血液相关异常。使用尿液样本进行基因检测和诊断分析是另一个关键部分，通常用于检测泌尿道感染、肾臟疾病和代谢紊乱。

根据应用，市场分为两类： 血糖监测产品包括用于监测血糖水平的设备和系统，这对于管理糖尿病和相关代谢状况至关重要。心臟代谢监测产品专注于监测心血管和代谢健康参数，帮助预防、诊断和管理高血压、血脂异常和心臟病等疾病。

护理点基因检测市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。

由于先进的医疗基础设施和有利的报销政策，北美和欧洲在采用方面处于领先地位。随着医疗保健投资的增加和个人化医疗意识的提高，亚太地区显示出巨大的成长潜力。在改善医疗保健服务和解决传染病负担的努力的推动下，拉丁美洲和非洲的新兴市场也正在见证这种技术的采用。总体而言，全球扩张和创新推动了床边基因检测不断发展的模式。

护理点基因检测市场-竞争格局：

该市场的特点是雅培实验室 (Abbott Laboratories)、赛默飞世尔科技 (Thermo Fisher Scientific) 和 Qiagen 等主要参与者之间的激烈竞争。这些公司以创新产品和策略性收购占据主导地位。 23andMe 和 Myriad Genetics 等新创公司在推动创新和市场颠覆方面也发挥着重要作用。重点仍然是开发用户友好且准确的测试解决方案，以满足不断变化的医疗保健需求。

最近的发展：

2023 年 1 月，Cipla Ltd. 推出了 Cippoint，这是一种即时检测设备，可识别多种健康状况，包括心臟标记、糖尿病、传染病、生育力和甲状腺功能。

目录

第 1 章：即时基因检测市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 护理点基因检测市场片段（依样本）
    • 护理点基因检测市场片段（按产品）
    • 按平台分類的护理点基因检测市场片段
    • 最终用户的护理点基因测试市场片段
    • 按国家/地区分類的护理点基因检测市场片段
    • 按地区分類的护理点基因检测市场片段
  • 竞争洞察

第 3 章：即时基因检测主要市场趋势

  • 即时基因检测市场驱动因素
    • 市场驱动因素的影响分析
  • 即时基因检测市场限制
    • 市场限制影响分析
  • 即时基因检测市场机会
  • 即时基因检测市场未来趋势

第 4 章：即时基因检测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：即时基因检测市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：即时基因检测市场格局

  • 2023 年护理点基因检测市占分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：即时基因检测市场 - 依样本

  • 概述
    • 细分市场占有率分析（按样本）
    • 血
    • 尿

第 8 章：即时基因检测市场 - 按产品

  • 概述
    • 按产品分類的细分市场占有率分析
    • COVID-19 测试产品
    • 血糖监测产品
    • 心臟代谢监测产品
    • 传染病检测产品
    • 凝血监测产品
    • 其他 POC 产品

第 9 章：即时基因检测市场 - 按平台

  • 概述
    • 按平台分類的细分市场占有率分析
    • 侧流分析
    • 量油尺
    • 微流控
    • 分子诊断
    • 免疫测定
    • 其他分子诊断技术

第 10 章：床边基因检测市场 - 按最终用户

  • 概述
    • 按产品分類的细分市场占有率分析
    • 临床实验室
    • 医院、重症监护中心、紧急护理中心
    • 家庭护理和自我测试

第 11 章：即时基因检测市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美床边基因检测主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按样本）
    • 北美市场规模和预测（按产品）
    • 北美市场规模和预测（按平台）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲床边基因检测主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按样本）
    • 欧洲市场规模和预测（按产品）
    • 欧洲市场规模和预测（按平台）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区床边基因检测主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按样本）
    • 亚太地区市场规模与预测（按产品）
    • 亚太地区市场规模和预测（按平台）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲的护理点基因检测主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按样本）
    • 拉丁美洲市场规模与预测（按产品）
    • 拉丁美洲市场规模与预测（按平台）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲床边基因检测主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按样本）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模及预测（按平台）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：关键供应商分析 - 护理点基因检测产业

  • 竞争仪表板
  • 公司简介
    • A. Menarini Diagnostics SRL
    • Abaxis
    • Abbott
    • Acon Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Ascensia Diabetes Care Holdings Ag
    • Bayer AG
    • bioMerieux
    • Bio-Rad Laboratories, Inc.
    • Danaher
    • Diasorin SPA
    • F. Hoffmann-La Roche AG
    • Fluxergy
    • Grifols, SA
    • Lifescan Ip Holdings, Llc
    • Mankind Pharma
    • Nipro Diagnostics
    • Nova Biomedical
    • OraSure Technologies, Inc.
    • Precision Biosensor, Inc.
    • QIAGEN
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2669

REPORT HIGHLIGHT

Point of Care Genetic Testing Market size was valued at USD 6,583.54 million in 2023, expanding at a CAGR of 12.35% from 2024 to 2032.

Point-of-care genetic testing involves genetic testing procedures conducted directly at the patient's location, providing immediate results for clinical decision-making. The increasing adoption of portable and handheld genetic testing devices facilitates decentralized testing and empowers patients with greater control over their healthcare. However, the market faces restraints such as regulatory challenges surrounding the interpretation and communication of genetic test results, and concerns about data privacy and security. Opportunities in this market stem from the potential for personalized medicine, where genetic testing at the point of care can guide treatment decisions tailored to individual patients' genetic profiles, leading to more effective healthcare delivery.

Point of Care Genetic Testing Market- Market Dynamics

Rising incidence of infectious diseases worldwide

The increasing prevalence of infectious diseases worldwide is driving a heightened need for Point of Care Genetic Testing (POCGT). According to the National Library of Medicine, infectious diseases continue to stand as one of the primary factors contributing to morbidity and mortality worldwide, responsible for over 52 million (33%) deaths annually on a global scale. With infectious diseases posing significant public health challenges globally, there is a pressing need for rapid and accurate diagnostic solutions that can be deployed directly at the point of care. Traditional laboratory-based testing methods often involve delays in diagnosis and treatment initiation, which can exacerbate the spread of infectious diseases. POCGT addresses this challenge by providing timely results, enabling healthcare providers to promptly identify infectious agents and initiate appropriate treatment strategies.

Point of Care Genetic Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.35% over the forecast period (2024-2032)

Based on sample segmentation, Blood was predicted to show maximum market share in the year 2023

Based on Platform segmentation, Lateral Flow Assays was the leading type in 2023

Based on End-user segmentation, Clinical Laboratories was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Point of Care Genetic Testing Market- Segmentation Analysis:

The Global Point of Care Genetic Testing Market is segmented on the basis of Sample, Product, Platform, End User, and Region.

The market is divided into two categories based on sample: Blood encompasses genetic testing and diagnostic procedures conducted using blood samples, offering insights into various health conditions such as infectious diseases, genetic disorders, and blood-related abnormalities. Genetic testing and diagnostic analysis using urine samples form another crucial segment, often utilized in detecting urinary tract infections, kidney diseases, and metabolic disorders.

The market is divided into two categories based on application: Glucose monitoring products encompass devices and systems for monitoring blood glucose levels, essential for managing diabetes and related metabolic conditions. Cardiometabolic monitoring products focus on monitoring cardiovascular and metabolic health parameters, aiding in the prevention, diagnosis, and management of conditions such as hypertension, dyslipidemia, and heart disease.

Point of Care Genetic Testing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America and Europe lead in adoption due to advanced healthcare infrastructure and favorable reimbursement policies. The Asia-Pacific region shows significant growth potential with increasing healthcare investments and rising awareness of personalized medicine. Emerging markets in Latin America and Africa are also witnessing adoption, driven by efforts to improve healthcare access and address infectious disease burdens. Overall, global expansion and innovation drive the evolving landscape of point-of-care genetic testing.

Point of Care Genetic Testing Market- Competitive Landscape:

The market is characterized by intense competition among key players such as Abbott Laboratories, Thermo Fisher Scientific, and Qiagen. These companies dominate with innovative products and strategic acquisitions. Startups including 23andMe and Myriad Genetics also play significant roles, in driving innovation and market disruption. The focus remains on developing user-friendly and accurate testing solutions to meet evolving healthcare needs.

Recent Developments:

In January 2023, Cipla Ltd. launched Cippoint, a point-of-care testing device that identifies a wide range of health conditions, including cardiac markers, diabetes, infectious diseases, fertility, and thyroid function.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL POINT OF CARE GENETIC TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

A. Menarini Diagnostics S.R.L.

Abaxis

Abbott

Acon Laboratories, Inc.

Agilent Technologies, Inc.

Ascensia Diabetes Care Holdings Ag

Bayer AG

bioMerieux

Bio-Rad Laboratories, Inc.

Danaher

Diasorin S.P.A.

F. Hoffmann-La Roche AG

Fluxergy

Grifols, S.A.

Lifescan Ip Holdings, Llc

Mankind Pharma

Nipro Diagnostics

Nova Biomedical

OraSure Technologies, Inc.

Precision Biosensor, Inc.

QIAGEN

Others

GLOBAL POINT OF CARE GENETIC TESTING MARKET, BY SAMPLE- MARKET ANALYSIS, 2019 - 2032

  • Blood
  • Urine

GLOBAL POINT OF CARE GENETIC TESTING MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • COVID-19 Test Products
  • Glucose Monitoring Products
  • Cardiometabolic Monitoring Products
  • Infectious Disease Testing Products
  • Coagulation Monitoring Products
  • Other POC Products

GLOBAL POINT OF CARE GENETIC TESTING MARKET, BY PLATFORM- MARKET ANALYSIS, 2019 - 2032

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays
  • Other Molecular Diagnostic Technologies

GLOBAL POINT OF CARE GENETIC TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Clinical Laboratories
  • Hospitals, Critical Care Centers, Urgent care centers
  • Home Care & Self Testing

GLOBAL POINT OF CARE GENETIC TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Point of Care Genetic Testing Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Point of Care Genetic Testing Market Snippet By Sample
    • 2.1.2.Point of Care Genetic Testing Market Snippet By Product
    • 2.1.3.Point of Care Genetic Testing Market Snippet By Platform
    • 2.1.4.Point of Care Genetic Testing Market Snippet By End User
    • 2.1.5.Point of Care Genetic Testing Market Snippet by Country
    • 2.1.6.Point of Care Genetic Testing Market Snippet by Region
  • 2.2.Competitive Insights

3.Point of Care Genetic Testing Key Market Trends

  • 3.1.Point of Care Genetic Testing Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Point of Care Genetic Testing Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Point of Care Genetic Testing Market Opportunities
  • 3.4.Point of Care Genetic Testing Market Future Trends

4.Point of Care Genetic Testing Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Point of Care Genetic Testing Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Point of Care Genetic Testing Market Landscape

  • 6.1.Point of Care Genetic Testing Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Point of Care Genetic Testing Market - By Sample

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Sample, 2023 & 2032 (%)
    • 7.1.2.Blood
    • 7.1.3.Urine

8.Point of Care Genetic Testing Market - By Product

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 8.1.2.COVID-19 Test Products
    • 8.1.3.Glucose Monitoring Products
    • 8.1.4.Cardiometabolic Monitoring Products
    • 8.1.5.Infectious Disease Testing Products
    • 8.1.6.Coagulation Monitoring Products
    • 8.1.7.Other POC Products

9.Point of Care Genetic Testing Market - By Platform

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Platform, 2023 & 2032 (%)
    • 9.1.2.Lateral Flow Assays
    • 9.1.3.Dipsticks
    • 9.1.4.Microfluidics
    • 9.1.5.Molecular Diagnostics
    • 9.1.6.Immunoassays
    • 9.1.7.Other Molecular Diagnostic Technologies

10.Point of Care Genetic Testing Market - By End User

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 10.1.2.Clinical Laboratories
    • 10.1.3.Hospitals, Critical Care Centers, Urgent care centers
    • 10.1.4.Home Care & Self Testing

11.Point of Care Genetic Testing Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Point of Care Genetic Testing Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Point of Care Genetic Testing Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Point of Care Genetic Testing Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Point of Care Genetic Testing Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Point of Care Genetic Testing Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Point of Care Genetic Testing Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.A. Menarini Diagnostics S.R.L.
    • 12.2.2.Abaxis
    • 12.2.3.Abbott
    • 12.2.4.Acon Laboratories, Inc.
    • 12.2.5.Agilent Technologies, Inc.
    • 12.2.6.Ascensia Diabetes Care Holdings Ag
    • 12.2.7.Bayer AG
    • 12.2.8.bioMerieux
    • 12.2.9.Bio-Rad Laboratories, Inc.
    • 12.2.10.Danaher
    • 12.2.11.Diasorin S.P.A.
    • 12.2.12.F. Hoffmann-La Roche AG
    • 12.2.13.Fluxergy
    • 12.2.14.Grifols, S.A.
    • 12.2.15.Lifescan Ip Holdings, Llc
    • 12.2.16.Mankind Pharma
    • 12.2.17.Nipro Diagnostics
    • 12.2.18.Nova Biomedical
    • 12.2.19.OraSure Technologies, Inc.
    • 12.2.20.Precision Biosensor, Inc.
    • 12.2.21.QIAGEN
    • 12.2.22.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Point of Care Genetic Testing Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, By Sample
  • TABLE Global Point of Care Genetic Testing Market, By Sample 2019-2032 (USD Million)
  • TABLE Point of Care Genetic Testing Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, By Product
  • TABLE Global Point of Care Genetic Testing Market, By Product 2019-2032 (USD Million)
  • TABLE Point of Care Genetic Testing Market: Distribution Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, By Platform
  • TABLE Global Point of Care Genetic Testing Market, By Platform 2019-2032 (USD Million)
  • TABLE Point of Care Genetic Testing Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, By End User
  • TABLE Global Point of Care Genetic Testing Market, By End User 2019-2032 (USD Million)
  • TABLE Point of Care Genetic Testing Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Point of Care Genetic Testing Market, by Region 2019-2032 (USD Million)
  • TABLE North America Point of Care Genetic Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Point of Care Genetic Testing Market, By Sample, 2019-2032 (USD Million)
  • TABLE North America Point of Care Genetic Testing Market, By Product, 2019-2032 (USD Million)
  • TABLE North America Point of Care Genetic Testing Market, By Platform, 2019-2032 (USD Million)
  • TABLE North America Point of Care Genetic Testing Market, By End User, 2019-2032 (USD Million)
  • TABLE Europe Point of Care Genetic Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Point of Care Genetic Testing Market, By Sample, 2019-2032 (USD Million)
  • TABLE Europe Point of Care Genetic Testing Market, By Product, 2019-2032 (USD Million)
  • TABLE Europe Point of Care Genetic Testing Market, By Platform, 2019-2032 (USD Million)
  • TABLE Europe Point of Care Genetic Testing Market, By End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Point of Care Genetic Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Point of Care Genetic Testing Market, By Sample, 2019-2032 (USD Million)
  • TABLE Asia Pacific Point of Care Genetic Testing Market, By Product, 2019-2032 (USD Million)
  • TABLE Asia Pacific Point of Care Genetic Testing Market, By Platform, 2019-2032 (USD Million)
  • TABLE Asia Pacific Point of Care Genetic Testing Market, By End User, 2019-2032 (USD Million)
  • TABLE Latin America Point of Care Genetic Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Point of Care Genetic Testing Market, By Sample, 2019-2032 (USD Million)
  • TABLE Latin America Point of Care Genetic Testing Market, By Product, 2019-2032 (USD Million)
  • TABLE Latin America Point of Care Genetic Testing Market, By Platform, 2019-2032 (USD Million)
  • TABLE Latin America Point of Care Genetic Testing Market, By End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Point of Care Genetic Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Point of Care Genetic Testing Market, By Sample, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Point of Care Genetic Testing Market, By Product, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Point of Care Genetic Testing Market, By Platform, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Point of Care Genetic Testing Market, By End User, 2019-2032 (USD Million)